The impact of nicotine replacement therapies on cigarette demand

Frank Chaloupka and John Tauras

Journal of Economics and Finance, 2004, vol. 28, issue 3, 395-403

Abstract: Over the past 20 years, several nicotine replacement therapies (NRTs) have been approved for use as smoking cessation aids, with over-the-counter use of these products approved beginning in 1996. To date, only one econometric study has examined the impact of NRT on cigarette demand, providing limited evidence that the availability of these products has reduced cigarette demand. This paper adds to this limited literature by examining the impact of NRT availability, pricing, and use on U.S. cigarette demand, concluding that NRT is a substitute for cigarettes and that the elasticity of cigarette demand with respect to NRT sales is-0.06. Copyright Academy of Economics and Finance 2004

Date: 2004
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (3)

Downloads: (external link)
http://hdl.handle.net/10.1007/BF02751741 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:jecfin:v:28:y:2004:i:3:p:395-403

Ordering information: This journal article can be ordered from
http://www.springer. ... cs/journal/12197/PS2

DOI: 10.1007/BF02751741

Access Statistics for this article

Journal of Economics and Finance is currently edited by James Payne

More articles in Journal of Economics and Finance from Springer, Academy of Economics and Finance Contact information at EDIRC.
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().